Discovers, develops, manufactures and sells pharmaceutical products such as cardiovasculars, anti-infectives, central nervous system agents,anti-inflammatories and antidiabetes agents; manufactures and markets orthopedic implants, including hip, knee and bone cement products used to replace joints which have deteriorated due to disease or injury; produces oral and craniomaxillofacial surgery and specialty surgical instruments, angioplasty catheters, stents and single-patient-use medical products used in diagnosis and treatment of artherscerotic cardiovascular disease. electrosurgical and ultrasonic surgery equipment, impotence and incontinence implants and vascular access and advanced drug delivery systems; produces animal vaccines and companion animal health products; and manufactures and markets consumer health care products, such as baby-care products and toiletries, hair care products, over-the-counter medications and antiseptic and germicidal products.
Key Financial Ratios And Statistics
Fiscal Year End: 12/31 Net Sales/Employee: $243,140
Annual Dividend: 0.68 Current Ratio: 1.15
EPS (12/31): 1.55 Quick Ratio: 0.69
Price/Earnings (12/31): 35.65
Return on Assets: 0.13 Return on Equity: 0.28
Net Sales (000's): $11,306,000 Net Income (000's): $1,929,000
Total Assets/Equity: 2.11 Total Debt/Equity: 0.10
Links to other sites on the Web
Get your own Free Home Page